Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(1.96)
# 1,871
Out of 5,090 analysts
55
Total ratings
34%
Success rate
-2.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Reiterates: Buy | $90 | $63.33 | +42.11% | 4 | Nov 28, 2025 | |
| MGTX MeiraGTx Holdings | Initiates: Buy | $20 | $8.65 | +131.21% | 1 | Nov 24, 2025 | |
| LYEL Lyell Immunopharma | Maintains: Neutral | $10 → $20 | $25.47 | -21.48% | 1 | Nov 24, 2025 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $40 → $30 | $6.88 | +336.05% | 1 | Nov 19, 2025 | |
| NGNE Neurogene | Maintains: Buy | $65 → $70 | $20.28 | +245.17% | 3 | Nov 13, 2025 | |
| KRRO Korro Bio | Downgrades: Neutral | n/a | $7.02 | - | 2 | Nov 13, 2025 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $5 → $10 | $3.95 | +153.16% | 1 | Nov 11, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $18 → $15 | $9.61 | +56.09% | 5 | Nov 10, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $100 → $110 | $81.68 | +34.67% | 6 | Nov 10, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Neutral | $60 → $55 | $53.40 | +3.00% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $20 | $7.80 | +156.41% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $30.84 | +29.70% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $13 | $9.35 | +39.04% | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $40 | $18.31 | +118.46% | 6 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $60 | $28.13 | +113.30% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $56.88 | +40.65% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $17.56 | +42.37% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $10.92 | +1,044.69% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.42 | +106.61% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $13.07 | +91.28% | 2 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sell | $5 | $22.26 | -77.54% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $21.50 | +39.53% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.78 | +293.26% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $3.74 | -46.52% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $11.12 | +25.90% | 1 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.14 | +250.88% | 1 | Aug 11, 2025 |
Halozyme Therapeutics
Nov 28, 2025
Reiterates: Buy
Price Target: $90
Current: $63.33
Upside: +42.11%
MeiraGTx Holdings
Nov 24, 2025
Initiates: Buy
Price Target: $20
Current: $8.65
Upside: +131.21%
Lyell Immunopharma
Nov 24, 2025
Maintains: Neutral
Price Target: $10 → $20
Current: $25.47
Upside: -21.48%
Cartesian Therapeutics
Nov 19, 2025
Maintains: Buy
Price Target: $40 → $30
Current: $6.88
Upside: +336.05%
Neurogene
Nov 13, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $20.28
Upside: +245.17%
Korro Bio
Nov 13, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.02
Upside: -
CytomX Therapeutics
Nov 11, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $3.95
Upside: +153.16%
Intellia Therapeutics
Nov 10, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $9.61
Upside: +56.09%
Ionis Pharmaceuticals
Nov 10, 2025
Maintains: Buy
Price Target: $100 → $110
Current: $81.68
Upside: +34.67%
BioMarin Pharmaceutical
Oct 27, 2025
Maintains: Neutral
Price Target: $60 → $55
Current: $53.40
Upside: +3.00%
Oct 27, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $7.80
Upside: +156.41%
Oct 27, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $30.84
Upside: +29.70%
Oct 21, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.35
Upside: +39.04%
Oct 21, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $18.31
Upside: +118.46%
Oct 17, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $28.13
Upside: +113.30%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $56.88
Upside: +40.65%
Sep 17, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $17.56
Upside: +42.37%
Sep 11, 2025
Reiterates: Buy
Price Target: $125
Current: $10.92
Upside: +1,044.69%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $2.42
Upside: +106.61%
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $13.07
Upside: +91.28%
Aug 25, 2025
Reiterates: Sell
Price Target: $5
Current: $22.26
Upside: -77.54%
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $21.50
Upside: +39.53%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.78
Upside: +293.26%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.74
Upside: -46.52%
Aug 14, 2025
Reiterates: Buy
Price Target: $14
Current: $11.12
Upside: +25.90%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.14
Upside: +250.88%